Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HMMR/RHAMM recruits SACK1D/FAM83D-CK1α complex at the mitotic spindle to control spindle alignment. | iScience | 2026 | 41550726 | PubTator, text mining | PubMed |
| Hyaluronic acid-based strategies for prostate cancer therapy. | Colloids Surf B Biointerfaces | 2026 | 41547114 | PubTator, text mining | PubMed |
| Single-cell profiling defines the cellular landscape of the urinary bladder: a scoping review. | Eur J Med Res | 2026 | 41491261 | PubTator, text mining | PubMed |
| CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human. | Adv Sci (Weinh) | 2026 | 41422437 | PubTator, text mining | PubMed |
| Effects of Urtica dioica agglutinin on the expression of hyaluronan synthase and cell surface hyaluronic acid receptor genes. | 3 Biotech | 2026 | 41376891 | PubTator, text mining | PubMed |
| A prisma-based systematic review on the effect of high and low molecular weight hyaluronic acid on IL-1, IL-6, IL-10, CD44, p53, and RHAMM in cellular response related to bone regeneration. | Int J Biol Macromol | 2026 | 41344468 | PubTator, text mining | PubMed |
| HMMR is a novel prognostic marker and a potential therapeutic target for colon cancer. | Cell Signal | 2026 | 41297832 | PubTator, text mining | PubMed |
| High hyaluronan binding and RHAMM expression identify an invasive and metastatic subpopulation in androgen-resistant prostate cancer cells. | Matrix Biol | 2026 | 41271182 | PubTator, text mining | PubMed |
| HMMR inhibition by 4-methylumbelliferone is effective in preclinical hepatocellular carcinoma models. | Histol Histopathol | 2026 | 40438003 | PubTator, text mining | PubMed |
| Prognostic value and experimental validation of atherosclerosis-derived pathogenic genes in colorectal cancer. | Front Oncol | 2025 | 41602397 | PubTator, text mining | PubMed |
| Understanding Fascial Tissue on the Molecular Level-How Its Unique Properties Enable Adaptation or Dysfunction. | Int J Mol Sci | 2025 | 41516037 | PubTator, text mining | PubMed |
| PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-β/Smad and PI3K/AKT/mTOR signaling. | Front Immunol | 2025 | 41488674 | PubTator, text mining | PubMed |
| Exploring the Link Between PACAP Signalling and Hyaluronic Acid Production in Melanoma Progression. | Int J Mol Sci | 2025 | 41465475 | PubTator, text mining | PubMed |
| Scratching in style: 3D printers as plotters for automated and complex wound-healing assays. | iScience | 2025 | 41446725 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney Pathology. | Biomolecules | 2025 | 41301516 | PubTator, text mining | PubMed |
| HMMR in human cancers: regulatory mechanism and biological function. | J Transl Med | 2025 | 41254645 | PubTator, text mining | PubMed |
| HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas. | Sci Rep | 2025 | 41253884 | PubTator, text mining | PubMed |
| Exploring MSC and HSPC interactions: new frontiers in hematopoiesis and transplant medicine. | Stem Cell Res Ther | 2025 | 41250227 | PubTator, text mining | PubMed |
| Integrative single-cell and bulk transcriptomes analyses reveal T cell-related prognostic risk model and tumor immune microenvironment modulation in colorectal cancer. | Transl Cancer Res | 2025 | 41234898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=3